The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 5, 2024 | Dhaliwal Jatinder | Director | Grant(A) | 3K | — | $0 |
| Jul 5, 2024 | Herman Gary L | Director | Grant(A) | 3K | — | $0 |
| Jul 5, 2024 | Field Katharyn | Director | Grant(A) | 3K | — | $0 |
| Jan 29, 2024 | Ruskin Barbara | Director | Grant(A) | 25K | — | $0 |
| Jan 29, 2024 | Floyd Eric | Director | Grant(A) | 45K | — | $0 |
| Jan 29, 2024 | Bruce Gerald W | Chief Executive Officer, Director | Grant(A) | 125K | — | $0 |
| Jan 29, 2024 | Sendrow Jerrold | Director | Grant(A) | 25K | — | $0 |
| Jan 29, 2024 | Dubin Michael F | Director | Grant(A) | 25K | — | $0 |
| Jan 29, 2024 | Mathias Sheila | Chief Scientific Officer | Grant(A) | 112K | — | $0 |
| Jan 29, 2024 | Jambulingam Thani | Director | Grant(A) | 25K | — | $0 |
| Jan 29, 2024 | Shah Vinay | Chief Financial Officer | Grant(A) | 112K | — | $0 |
| Jan 29, 2024 | Singh Vanila | Director | Grant(A) | 25K | — | $0 |
| Jun 20, 2023 | Shah Vinay | Chief Financial Officer | Grant(A) | 100K | — | $0 |
| Apr 24, 2023 | Bruce Gerald W | Director | Grant(A) | 100K | — | $0 |
| Mar 24, 2023 | Ruskin Barbara | Director | Grant(A) | 25K | — | $0 |
| Jan 25, 2023 | Chipman Christopher Michael | Chief Financial Officer | Grant(A) | 112K | — | $0 |
| Jan 25, 2023 | Gudin Jeffrey | Chief Medical Officer, Director | Grant(A) | 50K | — | $0 |
| Jan 25, 2023 | Mack Anthony P. | Chief Executive Officer, Director, 10% Owner | Grant(A) | 125K | — | $0 |
| Jan 1, 2023 | Singh Vanila | Director | Grant(A) | 15K | — | $0 |
| Jan 1, 2023 | Dubin Michael F | Director | Grant(A) | 20K | — | $0 |
| Jan 1, 2023 | Sendrow Jerrold | Director | Grant(A) | 35K | — | $0 |
| Jan 1, 2023 | Floyd Eric | Director | Grant(A) | 45K | — | $0 |
| Jan 1, 2023 | Jambulingam Thani | Director | Grant(A) | 40K | — | $0 |
| May 24, 2022 | Sendrow Jerrold | Director | Buy(P) | 5K | $1.29 | $6K |
| May 18, 2022 | Floyd Eric | Director | Buy(P) | 4K | $1.36 | $6K |
| May 18, 2022 | Mack Anthony P. | Chief Executive Officer, Director | Buy(P) | 76K | $1.34 | $102K |
| Apr 25, 2022 | Bruce Gerald W | Director | Grant(A) | 60K | — | $0 |
| Jan 31, 2022 | Chipman Christopher Michael | Chief Financial Officer | Grant(A) | 61K | — | $0 |
| Jan 31, 2022 | Mack Anthony P. | Chief Executive Officer, Director, 10% Owner | Grant(A) | 61K | — | $0 |
| Jan 31, 2022 | Gudin Jeffrey | Chief Medical Officer, Director | Grant(A) | 61K | — | $0 |
| Jan 1, 2022 | Jacob Gary S | Director | Grant(A) | 12K | — | $0 |
| Jan 1, 2022 | Floyd Eric | Director | Grant(A) | 15K | — | $0 |
| Jan 1, 2022 | Dubin Michael F | Director | Grant(A) | 12K | — | $0 |
| Jan 1, 2022 | Singh Vanila | Director | Grant(A) | 12K | — | $0 |
| Jan 1, 2022 | Jambulingam Thani | Director | Grant(A) | 14K | — | $0 |
| Jan 1, 2022 | Sendrow Jerrold | Director | Grant(A) | 12K | — | $0 |
| Nov 22, 2021 | Sendrow Jerrold | Director | Buy(P) | 4K | $3.93 | $15K |
| Nov 18, 2021 | Mack Anthony P. | Chief Executive Officer, Director, 10% Owner | Buy(P) | 25K | $3.99 | $100K |
| Jul 26, 2021 | Dubin Michael F | Director | Grant(A) | 20K | — | $0 |
| Apr 7, 2021 | Gudin Jeffrey | Chief Medical Officer, Director | Grant(A) | 50K | — | $0 |
| Apr 7, 2021 | Singh Vanila | Director | Grant(A) | 8K | — | $0 |
| Apr 7, 2021 | Jambulingam Thani | Director | Grant(A) | 10K | — | $0 |
| Apr 7, 2021 | Sendrow Jerrold | Director | Grant(A) | 10K | — | $0 |
| Apr 7, 2021 | Floyd Eric | Director | Grant(A) | 11K | — | $0 |
| Apr 7, 2021 | Chipman Christopher Michael | Chief Financial Officer | Grant(A) | 25K | — | $0 |
| Apr 7, 2021 | Mack Anthony P. | Chief Executive Officer, Director, 10% Owner | Grant(A) | 50K | — | $0 |
| Apr 7, 2021 | Jacob Gary S | Director | Grant(A) | 13K | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-14. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).